Chunxia, Q., Meiyun, H., Leiming, G., Ming, L., Zhou, L., Jing, G., . . . Beifen, S. (2012). Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formation. BMC.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)Chunxia, Qiao, et al. Structural Basis of LaDR5, a Novel Agonistic Anti-death Receptor 5 (DR5) Monoclonal Antibody, to Inhibit DR5/TRAIL Complex Formation. BMC, 2012.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)Chunxia, Qiao, et al. Structural Basis of LaDR5, a Novel Agonistic Anti-death Receptor 5 (DR5) Monoclonal Antibody, to Inhibit DR5/TRAIL Complex Formation. BMC, 2012.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.